论文部分内容阅读
美国科研人员22日宣布,他们在研制抗埃博拉病毒药物方面取得重要进展,猕猴试验结果显示该药物疗效达到60%。这种抗病毒药物属吗啉反义寡核苷酸化合物,能够抑制病毒在细胞内的繁殖,为免疫系统消灭入侵病毒赢得时间。
U.S. researchers announced on the 22nd that they have made important progress in developing anti-Ebola virus drugs, and the results of macaques showed that the drug achieves a 60% efficacy. The antiviral drug is a morpholine antisense oligonucleotide compound that inhibits the virus’s intracellular multiplication and gains time for the immune system to eliminate invading viruses.